{
    "2020-03-10": [
        [
            {
                "time": "",
                "original_text": "巨·研究| 全球医药外包产业链向国内转移 CRO/CMO企业迎机遇",
                "features": {
                    "keywords": [
                        "全球医药外包",
                        "产业链转移",
                        "CRO",
                        "CMO",
                        "国内"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "应对公共卫生紧急状态医药对策产品开发：FDA的实践与挑战",
                "features": {
                    "keywords": [
                        "公共卫生",
                        "紧急状态",
                        "医药对策",
                        "FDA",
                        "实践",
                        "挑战"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "公共健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}